share_log

CASI Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Panacea Venture Healthcare Fund II, L.P.(9.2%),Panacea Venture Healthcare Fund II GP Company, Ltd.(9.2%), etc.

CASI製藥 | SC 13G:超過5%持股股東披露文件-Panacea Venture Healthcare Fund II, L.P.(9.2%),Panacea Venture Healthcare Fund II GP Company, Ltd.(9.2%)等

美股SEC公告 ·  2023/04/10 11:22
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息